Moreover, CAFs release FAP, which activates AKT- and ERK-related signaling pathways, leading to the production of the aforementioned cytokines and the development of immunosuppressive properties in ESCC cells (96). This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.